State of Michigan Retirement System Has $7.26 Million Holdings in Msci Inc (NYSE:MSCI)

Share on StockTwits

State of Michigan Retirement System raised its position in shares of Msci Inc (NYSE:MSCI) by 12.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,756 shares of the technology company’s stock after buying an additional 2,356 shares during the quarter. State of Michigan Retirement System’s holdings in Msci were worth $7,263,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in MSCI. Pacer Advisors Inc. purchased a new stake in shares of Msci in the second quarter valued at $2,391,000. Shine Investment Advisory Services Inc. raised its position in Msci by 57.7% during the second quarter. Shine Investment Advisory Services Inc. now owns 164 shares of the technology company’s stock valued at $55,000 after buying an additional 60 shares during the period. Martin Investment Management LLC lifted its stake in Msci by 1.4% in the 2nd quarter. Martin Investment Management LLC now owns 20,042 shares of the technology company’s stock worth $6,690,000 after acquiring an additional 286 shares in the last quarter. GWM Advisors LLC lifted its stake in Msci by 4.7% in the 2nd quarter. GWM Advisors LLC now owns 2,828 shares of the technology company’s stock worth $944,000 after acquiring an additional 128 shares in the last quarter. Finally, Pitcairn Co. acquired a new stake in Msci during the 2nd quarter worth about $213,000. Institutional investors own 91.74% of the company’s stock.

NYSE MSCI opened at $375.98 on Friday. Msci Inc has a fifty-two week low of $206.82 and a fifty-two week high of $398.49. The stock’s 50-day moving average is $353.33 and its two-hundred day moving average is $315.44. The firm has a market cap of $31.45 billion, a P/E ratio of 61.33 and a beta of 0.94.

Msci (NYSE:MSCI) last issued its quarterly earnings data on Tuesday, July 28th. The technology company reported $1.77 EPS for the quarter, beating the Zacks’ consensus estimate of $1.68 by $0.09. Msci had a negative return on equity of 268.97% and a net margin of 32.14%. The business had revenue of $409.60 million for the quarter, compared to analyst estimates of $410.25 million. During the same quarter in the prior year, the firm posted $1.54 EPS. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. On average, analysts forecast that Msci Inc will post 7.27 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.83%. The ex-dividend date is Thursday, August 13th. This is an increase from Msci’s previous quarterly dividend of $0.68. Msci’s dividend payout ratio (DPR) is 42.24%.

MSCI has been the subject of a number of research analyst reports. UBS Group increased their price target on shares of Msci from $342.00 to $375.00 and gave the stock a “neutral” rating in a research report on Wednesday. Morgan Stanley increased their target price on shares of Msci from $337.00 to $366.00 and gave the stock an “equal weight” rating in a research report on Wednesday. BMO Capital Markets boosted their price target on shares of Msci from $346.00 to $501.00 and gave the company an “outperform” rating in a report on Wednesday, July 8th. Zacks Investment Research upgraded Msci from a “hold” rating to a “buy” rating and set a $369.00 price objective for the company in a report on Tuesday, July 7th. Finally, Deutsche Bank started coverage on Msci in a research note on Friday, July 17th. They issued a “hold” rating on the stock. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $346.44.

In other news, COO Cd Baer Pettit sold 2,500 shares of Msci stock in a transaction dated Monday, July 6th. The stock was sold at an average price of $347.47, for a total value of $868,675.00. Following the transaction, the chief operating officer now directly owns 283,045 shares in the company, valued at $98,349,646.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Scott A. Crum sold 3,500 shares of the business’s stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $376.69, for a total value of $1,318,415.00. Following the transaction, the insider now directly owns 29,279 shares of the company’s stock, valued at approximately $11,029,106.51. The disclosure for this sale can be found here. In the last three months, insiders sold 11,000 shares of company stock worth $3,770,165. Insiders own 2.94% of the company’s stock.

About Msci

MSCI Inc, together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. The company operates through four segments: Index, Analytics, ESG, and Real Estate. The Index segment primarily provides equity indexes for use in various areas of the investment process, including index-linked product creation and performance benchmarking, as well as portfolio construction and rebalancing, and asset allocation.

Featured Article: What are some reasons analysts would give stocks a buy rating?

Want to see what other hedge funds are holding MSCI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Msci Inc (NYSE:MSCI).

Institutional Ownership by Quarter for Msci (NYSE:MSCI)

Receive News & Ratings for Msci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Msci and related companies with MarketBeat.com's FREE daily email newsletter.

 

Latest News

Different Types of Research Papers
Different Types of Research Papers
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing


 
© 2006-2020 BBNS.